1 completed, 1 no longer available, 1 withdrawn. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Stephen Trokel: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Higher Irradiance in Keratoconus Ectasia UVA Light with irradiance exposure of 9 mW/cm2, Riboflavin 0.1% ophthalmic solution - Keratoconus, Ectasia | Not applicable | Withdrawn | Stephen Trokel | 2010-09-01 | 2023-02-09 | |
| Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Refractory Corneal Infection Riboflavin 0.1%, UV-X™ Illumination System - Corneal Ulcers | Phase 1 | Completed | Stephen Trokel | 6 | 2008-11-01 | 2023-02-09 |
| Progressive Keratoconus or Ectasia Treatment Plan Riboflavin Solution, UV-X Illumination System - Keratoconus, Ectasia | No longer available | Stephen Trokel | 2023-02-09 |
Dilatation, Pathologic (2) · Keratoconus (2) · Corneal Ulcer (1)
Ophthalmic Solutions (2) · Riboflavin (2)
United States (3)